TrianglePUBLICATIONS · 9862576
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Cancer
- Publication date
- 1998 Dec
- First author
- Nielsen OS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Nielsen OS
- type
- Author
- name
- Dombernowsky P
- type
- Author
- name
- Mouridsen H
- type
- Author
- name
- Crowther D
- type
- Author
- name
- Verweij J
- type
- Author
- name
- Buesa J
- type
- Author
- name
- Steward W
- type
- Author
- name
- Daugaard S
- type
- Author
- name
- van Glabbeke M
- type
- Author
- name
- Kirkpatrick A
- type
- Author
- name
- Tursz T
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Nielsen OS
- type
- Author
- name
- Dombernowsky P
- type
- Author
- name
- Mouridsen H
- type
- Author
- name
- Crowther D
- type
- Author
- name
- Verweij J
- type
- Author
- name
- Buesa J
- type
- Author
- name
- Steward W
- type
- Author
- name
- Daugaard S
- type
- Author
- name
- van Glabbeke M
- type
- Author
- name
- Kirkpatrick A
- type
- Author
- name
- Tursz T
- type
- Author
- bibliography ids
- nci-bib-92fdb7af0775b684cd2f89d7
- book metadata
- content sha256
- 98d91d3b837e22a1364686001efa286af3df368a5c4a61dcf9eddcf56e10dcb0
- document type
- citation
- dois
- 10.1038/bjc.1998.735
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:9862576
- immutable id
- pubmed:9862576@98d91d3b837e22a1364686001efa286af3df368a5c4a61dcf9eddcf56e10dcb0
- journal
- abbreviation
- Br J Cancer
- issn electronic
- 1532-1827
- issn print
- 0007-0920
- issue
- 12
- name
- British journal of cancer
- nlm unique id
- 0370635
- pages
- 1634-9
- volume
- 78
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 9862576
- provenance
- batch id
- 7e001e36165c25a91a06
- provider
- NCBI PubMed ESummary
- record sha256
- 93235c490979b5a3211c95d1890d41cc081b2991afc10580cfc057b33a95f047
- response sha256
- 3515b9c50c264ae766881ea5a6c5cb10e3af8e45341fd57a5bedfa1946d08222
- retrieved at
- 2026-09-09T23:45:31.509029+00:00
- publication date
- display
- 1998 Dec
- precision
- month
- year
- 1998
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/9862576/
- title
- High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
Preserved source evidence · Not medical advice